USPTO serial 87796085
MEROVEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 29, 2019
- Examiner
- DINALLO, KEVIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with MEROVEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dublin 2 D02 DK18, IE
Dublin 2 D02 DK18, IE
Dublin 2 D02 DK18, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael A. Marrero
Michael A. Marrero UB Greensfelder LLP312 WALNUT STREETSUITE 1400CINCINNATI, OH 45202-4029Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medical preparations and substances for treatment of dermatological conditions, psoriasis, erectile dysfunction, hair loss, urological conditions, bladder pain, prostate pain syndrome, gynecological conditions, endometriosis, recurrent pregnancy loss, vaginitis, osteoporosis, vitamin B12 deficiencies, for fertility purposes, oncological conditions, chronic myeloid leukemia, and bladder cancer, and for whitening and rejuvenating the skin, and for hormone replacement therapy; nasal sprays for medical purposes; decongestant nasal sprays; nasal rinse; suppositories; oral vaccine preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of diseases and disorders of the immune system; pharmaceutical preparations for the treatment of the immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treating and preventing diabetes; anti-infective antibiotics; anti-infective preparations; anti-infective products for veterinary use; anti-allergy sprays; anti-allergy preparations; pain relief preparations; pain relief medication; pain relief creams; acetaminophen; anti-inflammatory preparations; anti-inflammatory sprays and gels; anti-inflammatory ointment; pharmaceutical preparations and substances with anti-inflammatory properties; antipyretics preparations analgesics; pharmaceutical preparations and substances with antipyretics properties; pharmaceutical preparations and substances for use in urology; compounds for treating correlated pulmonary syndromes; pharmaceutical preparations and substances for use in the field of anaesthesia; hormones for medical purposes; oestrogen preparations; hormone suppressing preparations; hormone replacement preparations and substances; sanitary preparations for medical purposes; dietetic food and substances adapted for veterinary use, food for babies; medical plasters being materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; medicines for adjusting the menstrual cycle; topical analgesics; topical analgesics creams; topical anaesthetics | ACTIVE | — |
| 010 | [ Surgical apparatus and instruments; medical apparatus and instruments for vaginal tightening by ablation; dental apparatus for orthodontic correction; orthopaedic articles for treatment of diseases and conditions related to vitamin D deficiencies; suture materials; medical cutting devices; medical instruments, namely, for use in general surgery; electro medical instruments, namely, instruments for use in tightening the vagina for surgical ablation; medical devices for placing and securing catheters; optical instruments for medical endoscopy; laser instruments for medical use; medical instruments for cutting tissue; dialysis machines for medical use; medical instruments for therapeutic drug monitoring; medical instruments for recording physiological data; cell culture instruments for medical use; ] medical instruments for infectious disease testing [ ; impulse measuring instruments for medical use; medical instruments for drug abuse testing; medical instruments for application on human bodies, namely, instruments for orthodontic correction; laser light treatment instruments for medical use ] | ACTIVE | — |
| 040 | [ Custom manufacture of medical devices; custom assembling of electronic components for medical devices ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Meroven Limited
- Other trademarks owned by Meroven Limited
- Other trademarks owned by Meroven Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Similar marks named MEROVEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 18, 2025 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 15, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 14, 2025 | PR23 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | — |
| Nov 14, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 28, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 29, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 29, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 24, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 4, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 3, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2018 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 18, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 6, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 23, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 22, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 16, 2018 | NWAP | NEW APPLICATION ENTERED | — |